Goldman Sachs Group Inc Ocugen, Inc. Transaction History

Goldman Sachs Group Inc

$555 Billion
Q1 2024

A detailed history of Goldman Sachs Group Inc transactions in Ocugen, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 2,607,625 shares of OCGN stock, worth $4.51 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,607,625

Holding current value

$4.51 Million

% of portfolio

0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.5 - $1.83 $1.3 Million - $4.77 Million	2,607,625 New	2,607,625 $4.28 Million
Q2 2023 May 14, 2024	SELL	$0.45 - $0.88 $285,403 - $558,123	-634,231 Reduced 89.97%	70,669 $38,000
Q2 2023 Aug 14, 2023	SELL	$0.45 - $0.88 $285,403 - $558,123	-634,231 Reduced 89.97%	70,669 $38,000
Q1 2023 May 14, 2024	SELL	$0.82 - $1.33 $689,058 - $1.12 Million	-840,315 Reduced 54.38%	704,900 $599,000
Q1 2023 May 11, 2023	SELL	$0.82 - $1.33 $689,058 - $1.12 Million	-840,315 Reduced 54.38%	704,900 $599,000

Q4 2022 May 14, 2024	SELL	$1.11 - $1.87 $498,062 - $839,078	-448,705 Reduced 22.5%	1,545,215 $2.01 Million
Q4 2022 Feb 13, 2023	SELL	$1.11 - $1.87 $498,062 - $839,078	-448,705 Reduced 22.5%	1,545,215 $2.01 Million
Q3 2022 May 14, 2024	BUY	$1.75 - $3.1 $728,448 - $1.29 Million	416,256 Added 26.38%	1,993,920 $3.55 Million
Q3 2022 Nov 10, 2022	BUY	$1.75 - $3.1 $728,448 - $1.29 Million	416,256 Added 26.38%	1,993,920 $3.55 Million
Q2 2022 May 14, 2024	BUY	$1.83 - $3.45 $2.89 Million - $5.44 Million	1,577,664 New	1,577,664 $3.58 Million
Q2 2022 Aug 15, 2022	BUY	$1.83 - $3.45 $1.09 Million - $2.06 Million	596,736 Added 60.83%	1,577,664 $3.58 Million
Q1 2022 May 16, 2022	BUY	$2.34 - $4.72 $1.78 Million - $3.59 Million	760,306 Added 344.62%	980,928 $3.24 Million
Q4 2021 Feb 14, 2022	SELL	$4.38 - $15.67 $20,923 - $74,855	-4,777 Reduced 2.12%	220,622 $1 Million
Q3 2021 Nov 10, 2021	BUY	$6.36 - $8.51 $1.43 Million - $1.92 Million	225,399 New	225,399 $1.62 Million

Others Institutions Holding OCGN

# of Institutions

Shares Held

32.8M

Call Options Held

518K

Put Options Held

345K

View Full List

About Ocugen, Inc.

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $375M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

More about OCGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Ocugen, Inc. Transaction History